Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

June 30, 2020
Open Access

Optoacoustic skin mesoscopy opens a window to systemic effects of diabetes

MedRxiv : the Preprint Server for Health Sciences
H. HeVasilis Ntziachristos
July 2, 2020
Open Access

The potential therapeutic effects of Lactobacillus plantarum and inulin on serum and testicular reproductive markers in diabetic male rats

Diabetology & Metabolic Syndrome
Marziyeh Rahimiyan-HeravanKhadijeh Bavafa-Valenlia
July 2, 2020
Open Access

Cholecystectomy - a potential selection bias in studies assessing the metabolic effects of bariatric surgeries

Scientific Reports
Natasha Mendonça MachadoDan Linetzky Waitzberg
July 2, 2020

Functional status as a marker of need for hospital admission following outpatient hernia repair

Journal of Perioperative Practice
J Jeffery ReevesRuth S Waterman
July 2, 2020
Open Access

Functional Disability and Its Determinants in Ecuadorian Patients with Rheumatoid Arthritis

Open Access Rheumatology : Research and Reviews
Maria IntriagoCarlos Rios
July 1, 2020
Open Access

Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans

Arhiv za higijenu rada i toksikologiju
Ankica SekovanićMartina Piasek
July 2, 2020

Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients

Drug Metabolism and Personalized Therapy
Lettilia XhakazaMongi Benjeddou
July 1, 2020
Open Access

Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

BMC Nephrology
Kim M GoodingBEAt-DKD consortium
July 2, 2020

Metabolic effects of duodenojejunal bypass surgery in a rat model of type 1 diabetes

Surgical Endoscopy
Roman VangoitsenhovenAli Aminian
July 2, 2020
Open Access

Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes

Scientific Reports
Abdelkrim KhadirAli Tiss

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2020 Meta ULC. All rights reserved